Physician profile
Martin D Read
NPI 1164441044
$13,797.75
in general payments reported to CMS, 2019-2025
20 companies · $6,676 in 2025
The $6,676 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $344 · 2021: $295 · 2022: $332 · 2023: $402 · 2024: $5,633 · 2025: $6,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,600.00 |
| Food and Beverage | $1,111.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $11,600.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $567.69 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $423.49 | 2021-2025 | |
| Coopersurgical, INC. | $281.87 | 2020-2024 | Endosee |
| Biogen, INC. | $198.75 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $162.13 | 2022-2025 | Aptima, Novasure |
| Avion Pharmaceuticals | $156.51 | 2019-2022 | |
| Exeltis, USA INC. | $85.33 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $64.11 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $41.85 | 2021 | |
| Scynexis, INC. | $35.51 | 2022 | |
| Agile Therapeutics, INC. | $31.12 | 2021-2022 | |
| Organon LLC | $25.78 | 2021-2022 | |
| Pfizer INC. | $23.72 | 2023 | |
| Ethicon US, LLC | $23.00 | 2025 | Vistaseal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $18.64 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $18.11 | 2023 | Vivjoa |
| Alfasigma USA, INC. | $15.05 | 2021 | |
| Minerva Surgical, INC | $12.65 | 2019 | |
| Allergan, INC. | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.